openPR Logo
Press release

Influenza Vaccines Market 2023 - Size. Share, Segments, Data, Growth, And Forecast

09-21-2023 06:14 AM CET | Health & Medicine

Press release from: The Business research company

Influenza Vaccines Market

Influenza Vaccines Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Influenza Vaccines Global Market Report 2023 identifies rising incidences of seasonal influenza are expected to propel the growth of the influenza vaccine market. Influenza vaccines help in reducing the incidences of seasonal influenza by providing immunization against the circulating strains of the virus.

The global influenza vaccines market size is expected to grow from $6.45 billion in 2022 to $6.91 billion in 2023 at a compound annual growth rate (CAGR) of 7.19%. The size of influenza vaccines market is expected to reach $9.28 billion in 2027 at a CAGR of 7.63%.

Download Free Sample Of Influenza Vaccines Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Major players in the influenza vaccines market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, and Gamma Vaccines Pty. Ltd.

Technologically advanced vaccine production is a key trend gaining popularity in the influenza vaccine market. Companies operating in the influenza vaccine market are adopting advanced vaccine production technologies to sustain their position in the market.

Read More On The Global Influenza Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

The influenza vaccines market is segmented -
• By Vaccine Type: Inactivated, Live Attenuated
• By Valency: Quadrivalent, Trivalent
• By Route Of Administration: Injection, Nasal Spray
• By Age Group: Pediatric, Adult
• By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the influenza vaccines market.

The Business Research Company's "Global Influenza Vaccines Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Influenza Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

The Table Of Content For The Influenza Vaccines Market Include:
1. Influenza Vaccines Market Executive Summary
2. Influenza Vaccines Market Segments
3. Influenza Vaccines Market Size And Influenza Vaccines Market Growth Rate
4. Key Influenza Vaccines Market Trends
5. Major Influenza Vaccines Market Drivers
……
25. Key Mergers And Acquisitions In The Influenza Vaccines Market
26. Top Influenza Vaccines Companies
27. Influenza Vaccines Market Opportunities And Strategies
28. Influenza Vaccines Market, Conclusions And Recommendations
29. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Vaccines Market 2023 - Size. Share, Segments, Data, Growth, And Forecast here

News-ID: 3216004 • Views:

More Releases from The Business research company

Global Subcutaneous Immunoglobulin (SCIG) Market Projected to Grow at 12.7% CAGR, Reaching $23.23 Billion by 2029
Global Subcutaneous Immunoglobulin (SCIG) Market Projected to Grow at 12.7% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Subcutaneous Immunoglobulin (SCIG) Industry Market Size Be by 2025? The market for subcutaneous immunoglobulin (SCIG) has seen a swift expansion in the recent past. The market size is projected to escalate from $12.72 billion in 2024 to $14.39 billion in 2025, reflecting a compound annual growth
2025-2034 Ranibizumab Market Roadmap: Insights for Competitive Advantage
2025-2034 Ranibizumab Market Roadmap: Insights for Competitive Advantage
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Ranibizumab Market Size By 2025? The market for ranibizumab has experienced steady expansion in the past few years, with projections stating it will increase from $2.66 billion in 2024 to $2.76 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.6%. The growth
Emerging Peptide And Oligonucleotide CDMO Market Trends: Strategic Partnerships In Peptide And Oligonucleotide CDMO Market Boost Technological Capabilities And Market Reach Shaping the Future of the Industry
Emerging Peptide And Oligonucleotide CDMO Market Trends: Strategic Partnerships …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Peptide And Oligonucleotide CDMO Market Size Growth Forecast: What to Expect by 2025? In recent years, the peptide and oligonucleotide cdmo market has witnessed a swift escalation in its size. From $2.16 billion in 2024, it is projected to surge up to $2.42 billion in 2025 with a compound
Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chronic Disease Prevalence Drive Growth In The Oral Solid Dosage Pharmaceutical Formulation Market Market in 2025
Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chroni …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Oral Solid Dosage Pharmaceutical Formulation Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for oral solid dosage pharmaceutical formulations has seen robust growth in the last few years. Its size is expected to increase from $618.34 billion in 2024 to $653.26 billion in

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion